Back
Day Range
$9.11
$9.62
52-Week Range
$8.70
$22.96
Volume
1,053,748
50D / 200D Avg
$11.06
/
$12.79
Prev Close
$8.94
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.4 | 0.4 |
| P/B | 0.7 | 2.9 |
| ROE % | -39.9 | 3.7 |
| Net Margin % | -31.6 | 3.8 |
| Rev Growth 5Y % | 1.5 | 10.0 |
| D/E | 2.0 | 0.2 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 70,305 | — | — |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 8,089 | $9.61 | $77,735 |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
grant | 111,179 | — | — |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 8,487 | $9.61 | $81,560 |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
grant | 43,350 | — | — |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 7,247 | $9.61 | $69,644 |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
grant | 92,108 | — | — |
| Mar 10, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 687 | $9.55 | $6,561 |
| Mar 10, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 2,354 | $9.55 | $22,481 |
| Feb 2, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 89,606 | — | — |
| Nov 5, 2025 |
GRAVES JEFFREY A
Director
|
buy | 9,000 | $11.35 | $102,150 |
| Oct 12, 2025 |
Singh Harvinder
EVP & PRESIDENT, INTERNATIONAL
|
other | 27,211 | — | — |
| Jul 3, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 3,345 | $13.49 | $45,124 |
| Jul 3, 2025 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 2,561 | $13.49 | $34,548 |
| Jul 1, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 937 | $13.25 | $12,415 |
| May 9, 2025 |
BRADLEY KEITH
Director
|
other | 392 | $12.25 | $4,802 |
| May 9, 2025 |
BRADLEY KEITH
Director
|
grant | 19,592 | — | — |
| May 9, 2025 |
HILL BARBARA B
Director
|
grant | 26,531 | — | — |
| May 9, 2025 |
Clay Shaundra
Director
|
grant | 19,592 | — | — |
| May 9, 2025 |
Lo Renee Wonlai
Director
|
grant | 19,592 | — | — |
Key Takeaways
Revenue grew 1.47% annually over 5 years — modest growth
Negative free cash flow of -31.05M
Capital efficient — spends only 4.98% of revenue on capex
ROIC of 1.67% — low return on invested capital
Interest coverage of 0.79× — tight debt servicing
Growth
Revenue Growth (5Y)
1.47%
Revenue (1Y)1.53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-39.90%
ROIC1.67%
Net Margin-31.58%
Op. Margin4.18%
Safety
Debt / Equity
1.95
Current Ratio2.54
Interest Coverage0.79
Valuation
P/E Ratio
-1.42
P/B Ratio0.70
EV/EBITDA37.08
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.53% | Revenue Growth (3Y) | 2.99% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1.47% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.64B | Net Income (TTM) | -516.47M |
| ROE | -39.90% | ROA | -14.34% |
| Gross Margin | 51.69% | Operating Margin | 4.18% |
| Net Margin | -31.58% | Free Cash Flow (TTM) | -31.05M |
| ROIC | 1.67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.95 | Current Ratio | 2.54 |
| Interest Coverage | 0.79 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -1.42 | P/B Ratio | 0.70 |
| P/S Ratio | 0.45 | PEG Ratio | 0.00 |
| EV/EBITDA | 37.08 | Dividend Yield | 0.00% |
| Market Cap | 734.95M | Enterprise Value | 2.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.64B | 1.61B | 1.54B | 1.56B | 1.54B |
| Net Income | -516.47M | -6.94M | 67.74M | 180.55M | 169.08M |
| EPS (Diluted) | -6.73 | -0.09 | 0.84 | 2.16 | 1.98 |
| Gross Profit | 845.23M | 882.06M | 884.74M | 970.31M | 944.64M |
| Operating Income | 68.32M | 28.41M | 111.53M | 238.92M | 197.23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.60B | 4.04B | 3.78B | 3.89B | 3.78B |
| Total Liabilities | 2.56B | 2.49B | 2.19B | 2.09B | 2.10B |
| Shareholders' Equity | 1.04B | 1.55B | 1.59B | 1.80B | 1.68B |
| Total Debt | 2.03B | 1.98B | 1.68B | 1.63B | 1.67B |
| Cash & Equivalents | 235.05M | 246.38M | 276.40M | 456.66M | 513.45M |
| Current Assets | 1.16B | 1.08B | 1.06B | 1.16B | 1.15B |
| Current Liabilities | 455.98M | 922.13M | 306.98M | 320.91M | 340.02M |